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Homochirality of b-Peptides: A Significant Biomimetic
Property of Unnatural Systems
Istv#n M. M#ndity,[a] Imane Nekkaa,[a] G#bor Paragi,[b] and Ferenc Felçp*[a, c]
Homochirality, an interesting phenomenon of life, is mainly an
unresolved problem and was thought to be a property of
living matter. Herein, we show that artificial b-peptides have
the tendency toward homochiral diastereoselective chain elon-
gation. Chain-length-dependent stereochemical discrimination
was investigated in the synthesis of foldamers with various
side chains and secondary structures. It was found that there is
a strong tendency toward the synthesis of homochiral oligo-
mers. The size of the side chain drastically influenced the selec-
tivity of the stereodiscriminative chain-elongation reaction. It is
noteworthy that water as the co-solvent increases the selectivi-
ty. Such behavior is a novel fundamental biomimetic property
of foldamers with a potential of future industrial application.
Homochirality is an inherent property of vital polymers, for ex-
ample, peptides, proteins, RNA, DNA, as well as oligo- and
polysaccharides.[1] It is still not clear whether homochirality is
a result of an autocatalytic procedure[2] or if it originates from
extraterrestrial optically active non-racemic mixtures.[3] Numer-
ous investigations have been carried out by various research
groups to investigate the origin and role of this phenomen-
on.[1c, 4] In the case of peptides, mainly the stereochemical dis-
crimination in their synthesis has been investigated. For exam-
ple, a racemate of activated amino acids was reacted with
a given enantiomerically pure amino acid or peptide chain.
The results reveal a strong tendency for the formation of ho-
mochiral sequences.[5] This effect is even more dominant when
water is utilized as a co-solvent.[5a] In the case of self-templated
peptide fragment coupling, again, homochiral compounds are
formed.[6] On the other hand, when dipeptides were created,
heterochiral sequences appeared.[7] In the case of peptides
containing strongly structure-promoting a,a-disubstituted
amino acid, the formation of heterochiral sequences is favored
when large and bulky side chains are utilized.[8] However, for
smaller side chains, the synthesis of homochiral peptides is
preferred.[9] For similar sequences, helicity alone can govern
the direction of enantioselectivity. For example, P-helices favor
the incorporation of l-amino acids, whereas M-helices prefer
the coupling of the d-enantiomer.[10]
Foldamers are artificial self-organizing biomimetic poly-
mers.[11] These systems have a strong tendency to form highly
stable and versatile secondary structures, for example, helices,
strands, turns, and so on.[11g,12] Foldamers have numerous bio-
medical activities.[13] They are antibacterial amphiphills,[14] cell
and membrane penetrating peptides,[15] anti-Alzheimer com-
pounds,[16] and effectively modulate protein–protein interac-
tions.[17] Based on this fact, they are nowadays considered as
proteomimetics.[13a] Some of the most thoroughly investigated
foldamers are the b-peptides,[11d–f,18] which possess additional
biomimetic properties akin to natural a-peptides including hi-
erarchical self-organization,[19] conformational polymorphism,
and real folding reactions.[20]
Herein, we show that stereochemical discrimination towards
the homochiral oligomers manifests for b-peptides too, akin to
the biological homochirality of natural polymers. The phenom-
enon can be observed for various b-peptides with different
secondary structures, side-chain shape, and chain length.
b-Peptide foldamers containing various cyclic side chains
and possessing different secondary structures were selected
for the examination of diastereo-discriminative peptide cou-
pling with chain lengths varying from trimer to hexamer. As
a reference, a-l-leucine homooligopeptides were selected. The
investigated structures are shown in Scheme 1.
Oligomers 1–4 are composed of [1R,2R]-trans-2-aminocyclo-
pentanecarboxylic acid ([1R,2R]-trans-ACPC) building blocks
and they are known to form H12 helices.[11b] As a next step, for
compounds 5–8, the five-membered cyclic side chains were
changed for a six-membered cyclohexane ring, while retaining
the same stereochemistry. These oligomers were constructed
from [1R,2R]-trans-2-aminocyclohexanecarboxylic acid ([1R,2R]-
ACHC) residues.[11a] The formed secondary structure is a H14
helix. To investigate the effect of a strand structure, oligomers
created from [1S,2R]-cis-ACHC were also assembled (b-peptides
9–12). Homochiral homooligomers made from cis-b-amino
acids are known to form strand structures.[19,21] This fact is fur-
ther supported by a stereochemical patterning approach,
which declares that b-peptides possessing different stereo-
chemistry on the two sides of an amide bond form a strand
structure.[12b]
As control structures, homooligomeric a-peptides composed
of l-Leu were synthesized too (13–16). The isobutyl side chain
[a] Dr. I. M. M#ndity, I. Nekkaa, Prof. Dr. F. Felçp
Institute of Pharmaceutical Chemistry
University of Szeged
Eçtvçs u. 6, 6720 Szeged (Hungary)
E-mail : fulop@pharm.u-szeged.hu
[b] Dr. G. Paragi
MTA-SZTE Supramolecular and Nanostructured Materials Research Group
Djm t8r 8, 6720 Szeged (Hungary)
[c] Prof. Dr. F. Felçp
Research Group of Stereochemistry of the Hungarian Academy of Sciences
Djm t8r 8, 6720 Szeged (Hungary)
Supporting Information for this article can be found under:
https://doi.org/10.1002/open.201700078.
T 2017 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.
This is an open access article under the terms of the Creative Commons
Attribution License, which permits use, distribution and reproduction in
any medium, provided the original work is properly cited.
ChemistryOpen 2017, 6, 492 – 496 T 2017 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim492
DOI: 10.1002/open.201700078
was selected in accordance with the b-amino acids described
above, as only b-peptides comprising aliphatic side chains
were tested.
The peptides were assembled by utilizing highly efficient
continuous-flow solid-phase peptide synthesis technology de-
veloped in our laboratory.[22] The technology allows the con-
struction of various peptides by using very low, generally 1.5-
fold, amino-acid equivalents. The peptides were elongated in
the instrument, and the products were cleaved and purified
through regular reversed-phase HPLC methodology.
The stereochemical discrimination properties of the b-pep-
tides were tested by means of a solution-phase peptide-cou-
pling technique. The purified peptides were dissolved in a 2:1
mixture of dichloromethane (DCM) and N,N-dimethylforma-
mide (DMF). Subsequently, 10 equivalents of the tert-butyloxy-
carbonyl (Boc)-protected racemic amino acid was coupled by
using N,N’-diisopropylcarbodiimide (DIC) and hydroxybenzo-
triazole (HOBt) coupling agents. The reaction time was 48 h.
Importantly, the effect of water on the stereochemical discrimi-
nation was also investigated, as it is known to be a crucial fac-
tor.[5a,6] Thus, the reactions described above were performed in
the solvent system DCM/DMF/H2O 2:1:1 with a reaction time
of 48 h. The solvents were removed in vacuo and Boc depro-
tection was carried out by TFA treatment. Finally, the product
was lyophilized and the raw material was analyzed by using
HPLC–MS. The complete procedure is shown in Scheme 2 with
the example of oligomers built from trans-ACPC. The homochi-
ral chain-elongated reference compounds were always synthe-
tized independently and the heterochiral diastereomers were
deduced from the HPLC–MS chromatogram.
Based on the area integrals of the homochiral and heterochi-
ral peptides, the diastereomeric excess (DE) of the reaction was
calculated for all peptides in both the presence and the ab-
sence of water. The DE values are shown in Figure 1 in a chain-
length-dependent manner.
In the absence of water, a strong tendency towards the ho-
mochiral structures was observable for peptides containing the
[1R,2R]-trans-ACPC unit (1–4). A slight decrease in selectivity
was found as a function of chain length. The situation is com-
pletely different for the oligomers composed of [1R,2R]-trans-
ACHC (5–8), which contain a more bulky side chain. The selec-
tivity changed, the formation of the heterochiral product
became favored, and a nice chain-length-dependent correla-
tion was found. A change in selectivity towards the heterochi-
ral sequences in a stereo-discriminative chain elongation was
observed for peptides composed of a,a-disubstituted amino
acids with large bulky side chains.[9] A simple change in the
side chain caused a drastic difference in the stereochemical
discrimination properties of b-peptides. To investigate the
effect of cis relative configuration, compounds containing
[1S,2R]-cis-ACHC (9–12) were also studied. Again, a definite
tendency was observed towards the homochiral oligomers.
The chain length did not significantly alter the DE value. As
Scheme 1. The investigated structures possessing five- and six-membered
side chains and cis or trans relative configuration.
Scheme 2. The chain elongation of a b-peptide with a Boc-protected race-
mic amino acid yielding two diastereomers shown by the example of the
trans-ACPC residue.
Figure 1. DE values obtained for 1–4 (thin solid line), 5–8 (thick solid line),
9–12 (thin dashed line), and 13–16 (thick dashed line) in the absence (a)
and in the presence of water (b) as a function of chain length.
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a reference, a-peptides composed of l-Leu were investigated.
The diastereoselectivity showed a clear chain-length-depen-
dent manner and the homochiral product was favored. Impor-
tantly, the chain elongation of the trimer l-Leu showed only
very minor diastereo-differentiation.
In general, the presence of water enhanced the selectivity
toward the formation of homochiral homooligomers. In the
case of peptides built of [1R,2R]-trans-ACPC, DE values in-
creased compared to those formed in non-aqueous experi-
ments and a clear chain-length-dependent increase could also
be observed. The most dramatic difference compared to the
experiment performed without water can be observed for olig-
omers comprising [1R,2R]-trans-ACHC. The selectivity changed
to the opposite direction and homochiral compounds were
profoundly formed during the coupling of the Boc-protected
racemic trans-ACHC. In this case, a more dominant chain-
length-dependent fashion can be observed and, importantly,
the diastereoselective chain elongation of the hexamer
reached a DE of almost 90%. The effect of cis relative configu-
ration was also investigated in the presence of water. The re-
sults indicate again the profound formation of the homochiral
oligomer. Interestingly, DE values decreased to some extent as
a function of chain length. The reference l-Leu oligomers pre-
ferred the incorporation of the homochiral amino acids in
a chain-length-dependent manner. Nonetheless, water, in gen-
eral, increased the DE values compared to the results of the
water-free experiments.
To understand the effect of water in the diastereoselective
chain-elongation reaction, the effect of water on the foldamer-
ic systems itself should be considered. Foldameric systems are
known to show secondary structure-dependent self-association
with water as the solvent.[19,20] Helical structures self-associate
into vesicles, whereas strand structures form nano-sized fibrils.
It has been reported that the self-association of peptides is
a crucial factor behind biological homochirality.[5a,6] Conse-
quently, we turned to investigate the effect of self-association
of b-peptides on the stereochemical discrimination by means
of theoretical calculations. Oligomer 7, containing trans-ACHC,
has been selected as an example, as it showed the most dra-
matic water-dependent diastereo-discrimination.
Having a draft picture about the reaction barriers or possible
steric hindrances, DFT calculations were carried out at the
OLYP/tz2p level of theory.[23] This method can provide accepta-
ble geometries or reaction barriers for organic compounds.[24]
Transition states were calculated for the systems composed of
Boc-protected [1R,2R]- and [1S,2S]-trans-ACHC hydroxybenzo-
triazole ester and oligomer 6. The structure of the latter was
previously optimized in the form of a H14 helix. The reason for
selecting b-peptide 6 is that it forms a helical structure with
the shortest chain length,[11a] which is the optimum structure
for quantum chemical calculations with acceptable calculation
times. Solvent effects were taken into account by means of the
COSMO solvent model, utilizing the permittivity of chloroform
and water.[25] The calculated relative barrier energies are shown
in Table 1.
The reaction barrier of the heterochiral construct was found
to be lower than those for the homochiral one in both sol-
vents. Consequently, the simplified model system cannot re-
produce the changes in the trends caused by the absence or
presence of water.
However, investigating the 3D structure of the homo- and
heterochirally elongated compounds, self-association might in-
crease geometrical strain. To examine the effect of self-associa-
tion on the stereochemical discrimination in the chain elonga-
tion of b-peptides, further theoretical calculations were carried
out and first a membrane segment was constructed and opti-
mized by utilizing the MMFF94[26] force field. The assembly is
shown in Figure 2a. For this purpose, oligomer 7 was selected,
as it has been reported to form solely a H14 helix.[20]
Our effort to perform similar density functional investiga-
tions and calculate the height of the barrier was not successful,
because of the size of the systems. However, hetero- and ho-
Table 1. Relative barrier energies (in kcalmol@1) for the transition state of
the chain elongation 6 in water and chloroform.
Solvent Homochiral
chain elongation
Heterochiral
chain elongation
chloroform 2.4 1.0
water 4.8 0.0
Figure 2. a) Molecular model for the vesicular membrane segment formed
of 7 (top view). b) The incorporation of the heterochirally chain-elongated
construct to the membrane (grey-colored ball-and-stick representation). The
clashes of the side chains are depicted by the overlapping of the space fill-
ing model of the involved residues.
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mochirally elongated oligomers were merged into the mem-
brane. For the heterochiral constructs, a clear collision was
found between the helices of oligomer 7 building the mem-
brane segment and the investigated compound shown in Fig-
ure 2b. This interaction hinders and blocks the heterochiral
chain elongation, and, consequently, the formation of homo-
chiral oligomers is favored.
We can conclude that the biological homochirality as a prop-
erty is also occurring with unnatural compounds, like b-pep-
tide foldamers. The phenomenon was investigated by means
of diastereoselective amino-acid coupling. b-Peptide oligomers
composed of either cis or trans alicyclic b-amino acids showed
a tendency towards the homochiral constructs. The oligomers
composed of [1R,2R]-trans-ACHC residues showed an interest-
ing property. In non-aqueous solvent systems, these com-
pounds favored the formation of the heterochiral construct ;
whereas, in the presence of water, the opposite homochiral
oligomers were preferred. Theoretical calculations indicated
that water plays a crucial role in this phenomenon through the
induction of self-association. In all cases, water enhanced the
diasetereoselectivity towards the homochiral oligomers. This
property was observed for the l-Leu-containing reference a-
peptides, further underlining the key role of water in the in-
duction of biological homochirality. It should be noted that
a relationship between the chain length and diastereoselectiv-
ity of the chain-elongation reaction might be established in
the presence of water. In the case of oligomers composed of
trans-ACPC, trans-ACHC, or l-Leu residues, the longer chain
length provided higher DE values in the presence of water. For
the strand-forming compounds containing cis-ACHC residues,
in contrast, the chain length did not drastically influence dia-
stereoselectivity. The results gained in this fundamental study
might provide the basis for industrial synthesis of b-peptides.
Experimental Section
Peptide Synthesis
Homooligomer foldamers 1–16 were synthesized by using a stan-
dard solid-phase technique utilizing fluorenylmethyloxycarbonyl
(Fmoc) chemistry. The peptide chains were elongated on TentaGel
R RAM resin (0.19 mmolg@1) and the syntheses were carried out
manually on a 0.1 mmol scale. Couplings were performed with
HATU/DIPEA without difficulties. The formed peptide sequences
were cleaved from the resin with 95% trifluoroacetic acid (TFA)
and 5% H2O at room temperature for 3 h. TFA was then removed
and the resulting free peptides were solubilized in aqueous acetic
acid (10%), filtered, and lyophilized. The crude peptides were in-
vestigated by using HPLC–MS.
Diastereodiscriminative Coupling Reactions
In an illustrative procedure, solutions of peptides 1–16 (0.01 mmol)
were prepared separately with HOBt (0.12 mmol) and DIC
(0.12 mmol) in CH2Cl2/DMF (2:1) in the absence or in the presence
of water (2:1:1). Then Boc-protected racemic amino acids
(0.1 mmol) were added. The mixtures were stirred for 48 h, CH2Cl2
was removed by evaporation, and water was subsequently added
to the residue by liophilization. The product was treated with 95%
TFA and 5% water to remove Boc protecting groups. The solutions
were then stirred for 30 min, TFA was removed in vacuo, the resi-
due was diluted with water, and then lyophilized. Samples were
analyzed by using HPLC–MS.
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